- Global Pharma News & Resources

[2021] Anti-inflammatory Drugs Market – Develop Rapidly by Top Players: Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc

SEATTLE, May 05, 2021, (PHARMIWEB) —

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Leading market players are focused on researching and developing new anti-inflammatory drugs, which are expected to boost global anti-inflammatory drugs market growth. For instance, on February 27, 2020, Drs. Reddy’s Laboratories Ltd., a pharmaceutical company, introduces generic versions of Naproxen and Esomeprazole Magnesium, an anti-inflammatory drugs, equal doses of Vimovo (Naproxen and Esomeprazole Magnesium) with delayed dosing pills approved by the US Food and Drug Administration (US FDA).

Request a sample copy of this report@

Impact of Coronavirus (COVID-19) Pandemic

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to over 100 countries around the world and the World Health Organization has declared it a public health emergency. According to a World Health Organization report, an outbreak of coronavirus (COVID-19) has caused more than 65.87 million infected people worldwide, as of December 6, 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by causing disruption to the distribution channel, and by its financial impact on financial firms and markets. As a result of these lockdown, many countries such as Saudi Arabia, the UAE, Egypt and others are facing problems to transportation of these drugs.

Moreover, the COVID-19 epidemic has been effected in the supply of raw materials and chemicals, which are used to produce drugs such as anti-inflammatory drugs, which are expected to disrupt global anti-inflammatory drugs market growth soon.

The major players in the global anti-inflammatory drugs market are focused on the adoption of novel products and the introduction of anti-inflammatory drugs. For instance, in July 2018, Aurobindo Pharma received the U.S. Food and Drug Administration (FDA) for the manufacture and production of Ibuprofen pills, which are used to relieve pain and reduce fever. These capsules are similar to the generic Pfizer’s Advil Liquid-gel gels.

Buy This Complete A Business Report:

Detailed Segmentation:

  • Global Anti-inflammatory Drugs Market, By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
  • Global Anti-inflammatory Drugs Market, By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
  • Global Anti-inflammatory Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
  • Global Anti-inflammatory Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

View Press Release For More Information @

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US:

Mr. Shah

Coherent Market Insights,

1001 4th Ave,

#3200 Seattle, WA 98154, U.S.

Phone: US +1-206-701-6702/UK +44-020 8133 4027



Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-May-2021